Assessment of treatment efficacy and prognosis prediction after drug administration: "CTC measurement" *For research purposes only
Monitoring cancer prognosis with a minimally invasive method! For customers who want to assess treatment effectiveness after starting chemotherapy.
This is an introduction to "CTC measurement," which allows for the assessment of treatment effects and prognosis after drug administration conducted by our company. Measurements are taken using the "CellSearch System" from Janssen Diagnostics, which is approved by the FDA. It counts the number of circulating cancer cells in peripheral blood and monitors cancer prognosis using a minimally invasive method. 【Features】 ■ Counts the number of circulating cancer cells in peripheral blood ■ Monitors cancer prognosis using a minimally invasive method ■ Measurements are taken using the "CellSearch System" from Janssen Diagnostics, which is approved by the FDA *For more details, please refer to the PDF document or feel free to contact us.
- Company：トランスジェニック
- Price：Other
